The effects of local, i.v. and volatile anaesthetic agents on locomotion of human blood leucocytes were studied in vitro. Blood neutxophils and monocytes and PHA-activated lymphocytes were allowed to migrate in filters towards standard chemotactic agents and the effect of adding anaesthetic agents to the system was measured. The results showed that locomotion of all cell types was depressed reversibly by all classes of anaesthetics used at clinical concentrations. The pattern of depression varied according to the cell type under study and the class of anaesthetic used. The action of anaesthetics on chemically stimulated locomotion of leucocytes was analysed. It was concluded that the principal action of these drugs is primarily on the mechanism of locomotion itself, rather than on the capacity of the cells to detect and respond to concentration gradients of attractants. Serum albumin can protect against the inhibitory action of anaesthetics.
Infection following surgery is a common problem. A variety of factors may contribute to the pathogenesis of this infection, among which may be the anaesthetic drugs used. However, the role of anaesthesia in infection after operation is ill-defined. Moudgil and Wade (1976) have reviewed evidence that anaesthetic drugs may depress both specific and non-specific defences against infection and that this depression is important in postoperative morbidity.
One of the earliest events following tissue damage or the introduction of pathogenic bacteria to the tissues is the migration of leucocytes from blood vessels to the infected or injured area. This migration is chemotactic, its direction being determined by the influence of chemical substances released at, and diffusing from, the site of injury or infection. Granulocytes, mononuclear phagocytes and lymphocytes all show chemotactic locomotion. Disturbances of this locomotion are likely to enable bacteria to become established in the tissues. Halothane has been shown to depress neutrophil mobilization in vivo in response to i.p. injection of pseudomonas toxin (Bruce, 1966) , and anaesthetics have been shown to inhibit lymphocyte motility reversibly in vitro (Nunn, Sharp and Kimball, 1970) . Wilkinson (1975) reported that procaine depresses leucocyte locomotion to chemoattractants. However, there has been no comprehensive study of the effects of anaesthetic agents on chemotactic locomotion. We report a study of the effects of local, inhalation and i.v. anaesthetic agents on the migration of human blood neutrophils, monocytes and lymphocytes towards chemotactic agents in vitro.
The mode of action of anaesthetic agents at the cellular level is not understood. They may act through a number of effects on the functions of cell membranes, reviewed in detail by Seeman (1972) . Recently they have been shown to paralyse the contractile microfilament and microtubule systems in the cell cytoplasm (Poste, Papahadjopoulos and Nicolson, 1975) . If anaesthetics can be shown to have easily measurable effects on leucocytes, this should provide a convenient model for analysis of their action, since leucocyte populations are easily obtained and purified.
MATERIALS AND METHODS
Cells were prepared from peripheral blood samples, taken from healthy human volunteers, heparinized with preservative-free heparin (Evans Medical, Liverpool). Dextran 110 (Fison's Pharmaceuticals, Loughborough) was added to the samples (1 part dextran : 10 parts of blood) and the erythrocytes were allowed to sediment at room temperature for 1 h. The leucocyte-rich supernatant plasma was layered on a gradient of 10 parts of 34% Triosil (Nyegaard, Oslo) and 24 parts of 9% Ficoll (Pharmacia, Uppsala), and predominantly neutrophil or monocyte/lymphocyterich cell fractions were obtained by centrifugation at 400 £ for 30min. The cells were washed twice in Gey's balanced salt solution at pH 7.2 (Wilkinson, 1974) , and were resuspended in it to give a final count of approximately 10 6 cell/ml. In the case of lymphocytes, blast transformation was achieved by stimulation with 6 ng/ml of phytohaemagglutinin (Burroughs Wellcome, Beckenham). After incubation for 3 days at 37 °C in Eagle's MEM (Flow Laboratories Ltd, Irvine), supplemented with 10% foetal calf serum, in an atmosphere of 5% carbon dioxide, the transformed cells were harvested, washed and resuspended in Gey's solution at pH 7.2.
A modification of Boyden's method as described by Wilkinson (1974) was used to measure the migration of cells through a micropore filter towards a chemotactic agent. Casein (Merck, Darmstadt) was used as the standard chemotactic agent. The cells were placed above a micropore filter (pore size 3 [Am for neutrophil migration (Millipore, Bedford, Mass.) and 12 [j.m for monocyte or lymphocyte migration (Sartorius, Gottingen)). The lower chamber contained a solution of casein in Gey's solution so that a gradient was established between the cells above the filter and the chemotactic agent below ( fig. 1 ). Tests were incubated at FIG. 1. The apparatus for measuring leucocyte locomotion. The upper chamber is a sawn-off tuberculin syringe barrel, to the lower end of which is glued a micropore filter. The upper, cell-containing chamber is suspended through the lid of a sandwich box into the lower, chemoattractantcontaining chamber, a 5-ml glass beaker.
37 °C to allow cell migration. After incubation for 75, 120 and 180 min for neutrophils, monocytes and transformed lymphocytes respectively, the cell migration was halted by fixation in ethanol and the filters were stained with haematoxylin using a standard technique. The cell migration from the filter-top was calculated by determining the distance migrated by the "leading front" of the cells through the micropore filter towards the gradient of the chemotactic agent, casein ( fig. 2 ). The mean of five readings of the "cell fronts" on each filter was estimated. The significance of the difference in migration between the control cells and the cells treated with different anaesthetic agents was calculated by Student's t test.
Local anaesthetic agents
The different cell fractions were exposed to bupivacaine HC1 (Marcain, Duncan, Flockhart and Co. Ltd, London), prilocaine HC1 (Citanest, Astra Chemicals Ltd, Watford), cinchocaine HC1 (Nupercaine, Laboratoires CIBA, Rueil Malmaison, France), lignocaine HC1 (Laporte Industries, Ilford), cocaine (Boots Co. Ltd, Nottingham) and procaine HC1 (BDH Chemicals Ltd, Poole, Dorset). Test cells in the presence of 10~2 M to 10~6 M concentrations of the drug to be tested were placed above the filter in the upper chamber. The lower chamber contained casein 1 mg/ml and the same concentration of the drug as that above the filter. Thus, there was no gradient of the drug across the filter. In the control tests casein or the drug, or both, were omitted.
Cells were treated with a standard inhibitory concentration of the drug for different intervals from 10 to 60 min at 37 °C. They were then washed in Gey's solution to remove the drug and set up in tests either immediately after washing or after incubation at 37 °C without the drug for varying periods of time to allow functional recovery. Control tests were run simultaneously, in which the drug was re-incorporated after washing. The ability of the pretreated cells to migrate towards casein after washing was taken as an index of recovery.
I.v. inducing agents
Cells were treated with Althesin (Glaxo Laboratories Ltd, Greenford), methohexitone sodium (Brietal Sodium, Eli Lilly and Co. Ltd, Basingstoke), and thiopentone sodium (Intraval Sodium, May and Baker Ltd, Dagenham) at various concentrations of the drugs and their migration across the filter towards a standard concentration of casein was observed. Again, no concentration gradient of the drug was present across the filter. I.v. anaesthetic agents bind readily to serum proteins rendering the bound drug pharmacologically inert; tests of this effect were conducted by adding human serum albumin (HSA) to the lower chambers containing the drug and the chemoattractant (HSA 1 or 10 mg/ml).
Volatile agents
Halothane (Fluothane, I.C.I. Ltd, Macclesfield), trichloroethylene (Trilene, I.C.I. Ltd), diethyl ether (Macfarlan Smith Ltd, Edinburgh) and methoxyflurane (Penthrane, Abbott Laboratories Ltd, Queenborough) were vaporized in oxygen (6 litre/min) using Fluotec Mark III, Tritec, Ethertec and Pentec vaporizers (Cyprane, Keighley) respectively. Different volatile agents, in vapour form, were delivered to a reservoir bag with a controlled bleed valve. The vapour outlet was channelled into six nylon catheters from the outlet port of the reservoir bag. The flow through the catheters was regulated by adjusting the bleed valve. The test cells and the Gey's solution containing varying concentrations of casein (0.1-1.0 mg/ml) were equilibrated by bubbling the vapour through them for 20 min, and the final concentration achieved was estimated by gas chromatography. Oxygen only was bubbled through control cells and solutions. Following treatment with the vapour, cells were quickly placed in chemotaxis chambers to minimize the loss of drug from solution. The test chambers were placed in a sealed desiccator and flushed with the vapour for 5 min. The equilibrated system was incubated at 37 °C for the duration of the test.
Since it was difficult to maintain different concentrations of the volatile agent in the same test, the anaesthetic concentration was kept constant, and the concentration of casein was varied.
Cells were treated initially with anaesthetic vapour for 20 min to achieve equilibration of the drug. Half of these cells were then bubbled with oxygen for 10 min; the other half received no further treatment. Control cells had oxygen only for 30 min. Tests were then set up in a normal atmosphere and cell migration towards different concentrations of casein was compared in the three groups of cells.
Analysis by gas chromatography
Concentrations of halothane and trichloroethylene in the various Gey's solutions were measured by gas chromatography following an extraction procedure. Halothane concentrations were obtained by the method of Allott, Steward and Mapleson (1971) . Trichloroethylene was analysed following extraction into carbon disulphide, using toluene as an internal standard. In both cases the chromatography was performed on a 2-m column of 3% SE-30 on Chromosorb W (Phase Separations Ltd, Queensferry) operated isothermally at 360 K.
The performance of the experimental system was tested using a 1 % v/v halothane-in-oxygen mixture. After bubbling the vapour through the various solutions, consecutive sampling showed that equilibrium was reached within 15 min, and that the mean concentration of halothane was 0.87 mmol/litre (SD 0.04).
Experiments were performed to test the decay characteristics of the two anaesthetic agents in Gey's solution. The halothane concentration in a 10-ml sample, which had been equilibrated for 30 min and then left open to the atmosphere, showed no deterioration over a period of 15 min but thereafter decreased slowly to 80% of its initial value after 1 h. When samples were left in a sealed container flushed with the vapour, the decrease in the halothane concentration was slower, to 90% of its initial value in 3 h. In contrast, when samples were equilibrated and subsequently bubbled with oxygen, the halothane concentration decreased to 2% of its initial value in 5 min, and after 10 min had decreased to less than 0.005 mmol/litre. Similar results were obtained with trichloroethylene.
RESULTS

Local anaesthetics
A dose-dependent inhibition of locomotion ofhuman blood leucocytes towards casein, and other chemotactic agents tested, was observed on exposure to all the local anaesthetic agents tested. Figure 3 shows the migration of transformed lymphocytes exposed to various doses of bupivacaine. The dose-dependent inhibition of locomotion shown in that figure was typical of cells exposed to all local anaesthetic agents are presence of HSA 1 mg/ml protects against inhibition of neutrophil locomotion by lignocaine. The 50% inhibitory dose in the absence of HSA was 7 x 10~3 mol/litre, in its presence 3 x 10~2 mol/litre. Figure 4A illustrates that the inhibitory effect of lignocaine on the locomotion of blood monocytes was similar whether the cells were exposed for 10 min or 90 min. Cells exposed to lignocaine, washed free of the tested. Table I shows the inhibition of locomotion of leucocytes exposed to different local anaesthetics. Cocaine was the least inhibitory of these agents. All agents inhibited locomotion at concentrations which clinically effective for anaesthesia: lO mol/litre. All cell types were slowed by local anaesthetics, but the inhibitory effects of these drugs on monocyte and lymphocyte locomotion were more marked than those on neutrophil locomotion. The drug and tested immediately, showed no reversal of inhibition. However, cells incubated with lignocaine for up to 30 min, which were then washed and allowed to recover by incubation in drug-free medium, for 1 h at 37 °C, showed an almost complete recovery ( fig.  4B ). This reversal was not observed in cells which had been treated with local anaesthetic agents for longer than 30 min ( fig. 4B ). This may be a result of the capacity of local anaesthetics to cross the cell membrane to the cytoplasm where they may exert an effect, even after extracellular drug has been removed. It is of interest that procaine, covalently linked to HSA by diazotization, did not inhibit leucocyte locomotion, possibly because it was unable to penetrate the cell membrane.
I.v. anaesthetic agents
A dose-dependent inhibition of leucocyte locomotion towards a standard concentration of casein was observed under the influence of all the i.v. anaesthetics tested (table II) . On incorporation of HSA 10 mg/ml, which would be expected to bind non-covalently to this group of drugs, locomotion to casein was inhibited less by thiopentone 5 x 10~5 mol/litre in the presence of HSA (47% inhibition) than in its absence (89% inhibition).
Volatile agents
In these experiments, in view of the difficulty of testing a wide range of concentrations of a volatile drug simultaneously, locomotion was measured using varying doses of casein and one or two selected concentrations of anaesthetic, for example 1 or 2% halothane. Exposure of all cell types to these concentrations caused suppression of locomotion. It was found that 1% halothane caused cells to migrate a shorter distance towards casein than untreated cells moved in the absence of a chemoattractant ( fig. 5 ), which suggests strongly that a major effect of these drugs is to paralyse the locomotor machinery of the cell. Whether the volatile agents also affect the ability of leucocytes to detect a chemotactic gradient cannot be established with certainty from such experiments. Table III shows that monocyte and lymphocyte locomotion is less sensitive to inhibition by volatile agents than neutrophil locomotion. This is in contrast to the finding that monocytes and lymphocytes are more sensitive than neutrophils to local anaesthetic agents. The migration of monocytes is compared with that of lymphocytes in figure 6 . Methoxyflurane was the most inhibitory drug for both cell types, but differences were seen in the actions of other drugs on the two types of cell. The effects of volatile anaesthetic agents on leucocyte motility were reversible upon removal of the anaesthetic and bubbling oxygen through the cell suspension for 10 min ( fig. 7) . 
DISCUSSION
This study has demonstrated that anaesthetic drugs of all the major groups-local, i.v. and inhalationprofoundly depress the locomotion of the leucocytes of the blood. Both phagocytic cells, with an important role in non-specific immunity, and lymphocytes, the mediators of specific immunity, were immobilized by anaesthetic agents. Differences in the susceptibility of the different cell types to different drugs were observed. These may reflect differences in membrane structure and function among the different cells, which are not understood at present. The results described here differ from earlier reports (Goldacre, 1952; Bruce and Christiansen, 1965; Nunn, Sharp and Kimball, 1970) of anaesthetic depression of leucocyte locomotion in showing that it was the ability of leucocytes to respond to chemical attractants which was inhibited and not merely unstimulated leucocyte locomotion. The immobilizing effect of anaesthetic agents on leucocytes is reversible. After short exposures, the reversibility is rapid but if the cells are exposed for a longer period they may not show full recovery. Presumably, drugs which are still for the greater part external to or easily accessible on the cell membrane may be removed by washing, but once they have reached the interior of the cell they may be much more difficult to remove.
The concentrations of anaesthetic agents used in these studies are those which would be expected to be used clinically in anaesthesia. Therefore it is possible that the paralysis of leucocyte locomotion observed in vitro occurs also in the tissues of anaesthetized subjects and that this phenomenon is of importance in lowering the resistance of such patients to infection. However, our laboratory assay uses a system in which the complex composition of the tissue fluids has been reduced to a simple balanced salt solution. It remains to be demonstrated that anaesthetic agents have an inhibitory effect on leucocyte locomotion in the living body similar to those occurring in vitro. In the presence of HSA, inducing and local agents still inhibited leucocyte locomotion but less than without HSA Binding to HSA renders such drugs inert as anaesthetic agents.
The site of action of anaesthetic agents on leucocytes is not known. They depress the locomotor capacity of the cells and their ability to respond to stimulation by chemoattractants rather than specifically affecting chemotactic locomotion in gradients. Leucocyte locomotion is microfilament driven and probably requires a metabolic burst on the part of the cell. Colchicine-treated leucocytes migrate well but do not respond to gradients (Bandmann, Rydgren and Norberg, 1974; Russell et al., 1975) . Since anaesthetic agents have effects on leucocyte locomotion which are quite unlike those of colchicine, it is unlikely that their primary effect is on microtubules, although they have been shown to disrupt microtubules (Allison, 1974; Poste, Papahadjopoulos and Nicolson, 1975) . It is more likely that an effect on microfilaments, as has been described for local anaesthetic-treated fibroblasts (Poste, Papahadjopoulos and Nicolson, 1975) , or on the cell membrane (Seeman and Roth, 1972; Rabinovitch and de Stefano, 1976) would account for the findings described here. Effects on ion exchange across the plasma membrane, on cation binding by membrane phospholipids and on membrane fluidity require to be investigated. Macrophages treated with local anaesthetic agents lose their locomotor morphology and become rounded (Rabinovitch and de Stefano, 1976) , a process which is reversible and probably related to the phenomena we have described in this paper.
How do anaesthetic agents affect locomotion ?
Since chemotactic factors may stimulate enhanced random locomotion (positive chemokinesis) and directional locomotion (chemotaxis) of leucocytes, it is necessary to determine how any drug which can be shown to inhibit cell movement acts on these responses of the cell. Effects on random locomotion can be determined by varying the absolute concentration of the chemoattractant, but keeping the concentration uniform above and below the filter so that there is no gradient. Effects on chemotaxis can be determined by varying the gradient as described by Zigmond and Hirsch (1973) . The effects of two local anaesthetic agents, procaine and prilocaine, were tested on neutrophils migrating under these denned conditions. The major effects of these drugs were shown to be an inhibition of the capacity of the cell to respond to the attractant irrespective of the gradient in which it was moving. No effect of procaine on the ability of neutrophils to detect a gradient was noted. In the experiment with prilocaine, it was possible that the cells showed reduced capacity to migrate chemotactically in gradients, but the results were equivocal. We conclude that the major effects of anaesthetic agents are on the locomotor capacity of leucocytes rather than on their locomotor orientation in gradients.
Further studies of the effects of anaesthetic agents on leucocyte locomotion are required, first because they may provide a useful model for explaining the mode of action of anaesthetics at the molecular and cellular level, and second to establish how important these effects are in clinical morbidity. 
INHIBITION PAR LES AGENTS ANES
SUMARIO
Los efectos de anestesicos locales, i.v. y volatiles sobre la locomocion de leucocitos en sangre humana fueron estudiados in vitro. Se dejo que neutrofilos y monocitos y linfocitos activados con PHA emigrasen en filtros hacia agentes quimiotacticos y se midio el efecto de anadir anestesicos al sistema. Los resultados mostraron que la locomocion de todos los tipos de globulos se hallaba deprimida reversiblemente por todas las clases de anestesicos utilizados a concentraciones clinicas. La caractistica de depresion variaba segun el tipo de gl6bulo estudiado y la clase de anestesico usado. Se analizo la accion de los anestesicos sobre la Iocomoci6n leucocitaria quimicamente estimulada. Se saco en conclusion que la accion principal de estos farmacos es primordialmente sobre el mecanismo locomotor en si, mas bien que sobre la capacidad de los globulos de detectar y responder a gradientes de concentration de los atrayentes.
